Biotechnology
Health
Medical

Cara Therapeutics

24,664

$13.00
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.18 (+1.40%) As of 2:46 PM EDT today
+$0.18 (+1.40%) Today

Why Robinhood?

You can buy or sell CARA and other stocks, options, ETFs, and crypto commission-free!

About CARA

Cara Therapeutics, Inc. Common Stock, also called Cara Therapeutics, is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics. Read More Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain. The company was founded by Derek T. Chalmers, Michael E. Lewis, and Frederique Menzaghi on July 2, 2004 and is headquartered in Stamford, CT.

CEO
Derek T. Chalmers
Employees
67
Headquarters
Stamford, Connecticut
Founded
2004
Market Cap
610.79M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
499.11K
High Today
$13.85
Low Today
$12.82
Open Price
$13.40
Volume
379.53K
52 Week High
$27.55
52 Week Low
$8.88

Collections

Biotechnology
Health
Medical
Research And Development
Pharmaceutical
Technology
Therapy
2014 IPO

CARA Earnings

-$0.74
-$0.49
-$0.25
$0.00
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 5, After Hours

People Also Bought

Corbus Pharmaceuticals

55,339

$4.99

+2.04%

Corbus Pharmaceuticals

55,339

$4.99

+2.04%

Zynerba Pharmaceuticals

27,522

$3.50

+5.74%

GW Pharmaceuticals

14,561

$84.71

+3.55%

Viking Therapeutics

52,040

$4.50

+2.16%

You May Also Like

LGF.A
FRGI
ATTO
IFV
LDUR
HHHHU
CII
UPRO
GRTS
VRP
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy CARA

Market Price$13.00
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell CARA stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up